Kenneth L. Londoner - 01 Sep 2021 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Issuer symbol
BSGM
Transactions as of
01 Sep 2021
Net transactions value
+$17,337
Form type
4
Filing time
02 Sep 2021, 12:56:58 UTC
Previous filing
31 Aug 2021
Next filing
29 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Purchase $13,624 +4,400 +0.26% $3.10* 1,709,458 01 Sep 2021 Direct F1
transaction BSGM Common Stock Purchase $3,713 +1,200 +0.07% $3.09* 1,710,658 02 Sep 2021 Direct F2
holding BSGM Common Stock 1,181,324 01 Sep 2021 By Endicott Management Partners, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.09 to $3.097, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.22, inclusive.
F3 The Reporting Person is the beneficial owner of Endicott Management Partners, LLC.